The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Effects of topiramate on cognitive function
Open accessAbstract
OBJECTIVE: To explore the impact of topiramate on tests of intellect and other cognitive processes. METHODS: This was a retrospective study. The neuropsychological test scores of 18 patients obtained before and after the introduction of treatment with topiramate (median dose 300 mg) were compared with changes in test performance of 18 patients who had undergone repeat neuropsychological assessments at the same time intervals. Complaints of cognitive decline precipitated referral for reassessment in five cases in the topiramate treated group. The groups were matched for age and intellectual level at the time of the first assessment. Patients were assessed using the WAIS-R, tests of verbal and non-verbal memory, language, and perceptual processing. A subgroup of patients underwent a brief reassessment after the withdrawal or substantial reduction of topiramate. RESULTS: Repeat assessments in those taking topiramate were associated with a significant deterioration in many domains, which were not seen in the comparison group. The greatest changes were for verbal IQ, verbal fluency, and verbal learning (p<0. 001). Improvements in verbal fluency (p<0.05), verbal learning (p<0. 01), and digit span (p<0.001) were recorded in those patients who had topiramate withdrawn or reduced. CONCLUSIONS: In our patient group topiramate had a negative impact on cognition which was consistent with subjective complaints of patients. Tests requiring verbal processing seemed especially sensitive to the drug. A decline in verbal intellect (VIQ), a measure which has been considered by some to be insensitive to antiepileptic drug effects, was particularly striking. Caution is warranted in the interpretation of the findings due to methodological limitations of the study design. Further investigation of mediating factors such as serum concentrations, comedication, and other potential risk factors, however, is needed to enable appropriate targeting of treatment with this effective antiepileptic agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults
Martin, R., Kuzniecky, R., Ho, S., Hetherington, H., Pan, J., Sinclair, K., Gilliam, F., & Faught, E. (1999) · Neurology · doi:10.1212/wnl.52.2.321 · Cited by 369
Privitera, M., Fincham, R., Penry, J., Reife, R., Kramer, L., Pledger, G., & Karim, R. (1996) · Neurology · doi:10.1212/wnl.46.6.1678 · Cited by 339
Jokeit, H., & Ebner, A. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.1.44 · Cited by 314
Faught, E., Wilder, B. J., Ramsay, R. E., Reife, R. A., Kramer, L. D., Pledger, G. W., & Karim, R. M. (1996) · Neurology · doi:10.1212/wnl.46.6.1684 · Cited by 289
Elterman, R. D., Glauser, T. A., Wyllie, E., Reife, R., Wu, S.-C., Pledger, G., & the Topiramate YP Study Group (1999) · Neurology · doi:10.1212/wnl.52.7.1338 · Cited by 235
Cognitive side-effects of chronic antiepileptic drug treatment: A review of 25 years of research
Vermeulen, J., & Aldenkamp, A. P. (1995) · Epilepsy Research · doi:10.1016/0920-1211(95)00047-x · Cited by 223
Tassinari, C. A., Michelucci, R., Chauvel, P., Chodkiewicz, J., Shorvon, S., Henriksen, O., Dam, M., Reife, R., Pledger, G., & Karim, R. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00649.x · Cited by 190
WORD-COMPREHENSION AND WORD-RETRIEVAL IN PATIENTS WITH LOCALIZED CEREBRAL LESIONS
COUGHLAN, A. K., & WARRINGTON, E. K. (1978) · Brain · doi:10.1093/brain/101.1.163 · Cited by 159
Topiramate - Safety and Tolerability
Jones, M. W. (1998) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100034855 · Cited by 65
Cited by
Cognitive side effects of antiepileptic drugs
Ortinski, P., & Meador, K. J. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.11.008 · Cited by 316
Cooper, S. J., Reynolds, G. P., order):, W. E. C.-A. (. A., Barnes, T., England, E., Haddad, P., Heald, A., Holt, R., Lingford-Hughes, A., Osborn, D., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116645254 · Cited by 292
Pediatric Idiopathic Intracranial Hypertension
Rangwala, L. M., & Liu, G. T. (2007) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2007.08.018 · Cited by 263
Acute and prophylactic effects of anticonvulsants in bipolar depression
Post, R. M., Speer, A. M., Obrocea, G. V., & Leverich, G. S. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00047-6 · Cited by 20
Metadata
- Authors
- Thompson, P. J.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2000-11-01
- Volume
- 69
- Issue
- 5
- Pages
- 636-641
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2157909788
- Cited by
- 257
- References
- 9
- FWCI
- 12.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of topiramate on cognitive function. https://app.cochat.ai/papers/10.1136/jnnp.69.5.636
- The paper
- Thompson, P. J. (2000). Effects of topiramate on cognitive function. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.69.5.636
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.